Meanwhile, it is also be found that the antigen-specific serum antibody responses, especially the antibody response to PT (Figure 4A) is faster with the novel vaccine already after the second dose compared to PT+FHA, which could provide another clue to faster clearance of pertussis in vivo. Here, F2 is linked to pertussis.